These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Ongoing||2005-001217-17||Comparison of venlafaxine augmentation with lamotrigine, quetiapine, or placebo in treatment resistant depression||not-yet-due|
|Ongoing||2006-001337-17||Characterisation of multiple sclerosis pathology by “ultra small particles of iron oxide (USPIO)” in comparison with conventional and advanced MRI imaging techniques||not-yet-due|
|Ongoing||2006-001491-21||Studies on Permeability of the Blood-Brain-Barrier for Escitaloprame related to various Genotypes of the ABCB1-Gene: Effects on Sleep and Motoric Learning||not-yet-due|
|Exempt||2006-004764-31||Effects of corticotropin-releasing hormone on sleep electroencephalogram and sleep associated hormone secretion in young healthy women||not-yet-due|
|Ongoing||2008-000453-35||Open-label phase IIa pilot study exploring safety and potential efficacy of recombinant human erythropoietin in early mild Alzheimer Dementia and therapy-refractory Major Depression (“EPO-AD”)||not-yet-due|
|Completed, but no date Terminated||2009-014909-14||Neuropsychological effects of hydrocortisone substitution in patients with partial adrenal insufficiency after traumatic brain injury or subarachnoidal haemorrhage||bad-data|
|Not reported Terminated||2010-020679-21||Growth hormone and gonadotropin deficiency after brain injury (traumatic brain injury, subarachnoidal hemorrhage, ischemic stroke): the effects of hormone replacement on cognition,quality of life and ...||2015-03-31||due-trials|
|Other||2014-000265-43||A randomized, placebo-controlled trial comparing the treatment effect of Pegvisomant and the SSRI Escitalopram on depressive acromegalic patients||not-yet-due|